Jubilant Organosys Ltd, headquartered in India, announced that its subsidiary in Canada, Draxis has received approval for the generic Sestamibi from Health Canada. Draximage Sestamibi is a generic Kit for the Preparation of Technetium (Tc 99m) Sestamibi Injection, a diagnostic cardiac imaging agent used for the diagnosis and localization of myocardial infarction; and for the diagnosis and localization of ischemic heart disease and coronary artery disease.
The details can be read here.
No comments:
Post a Comment